Choroidal Neovascularisation
Also known as: Choroidal neovascular membrane (disorder) / Choroidal neovascularization
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB01270 | Ranibizumab | A recombinant humanized monoclonal antibody and VEGF-A antagonist used for the management of macular edema after retinal vein occlusion, age-related macular degeneration (wet), and diabetic macular edema. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB01270 | Ranibizumab | Vascular endothelial growth factor A | target |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB01270 | Ranibizumab | 2 | Completed | 1 |
| DB00112 | Bevacizumab | 3 | Unknown Status | 1 |